Alkeon Capital Management - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 177 filers reported holding TG THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.

Quarter-by-quarter ownership
Alkeon Capital Management ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$38,449,215
-5.0%
1,547,875
-42.5%
0.07%
-24.7%
Q1 2023$40,456,442
+12.3%
2,689,923
-11.6%
0.09%
-36.0%
Q4 2022$36,015,453
+270.3%
3,044,417
+85.3%
0.14%
+348.4%
Q3 2022$9,725,000
+29.5%
1,642,675
-7.0%
0.03%
+55.0%
Q2 2022$7,511,000
-56.1%
1,767,130
-1.7%
0.02%
-41.2%
Q1 2022$17,099,000
-51.8%
1,798,010
-3.8%
0.03%
-48.5%
Q4 2021$35,498,000
-73.8%
1,868,301
-54.1%
0.07%
-71.2%
Q3 2021$135,393,000
-14.5%
4,068,301
-0.3%
0.23%
-2.1%
Q2 2021$158,360,000
-19.7%
4,082,495
-0.2%
0.23%
-20.1%
Q1 2021$197,171,000
-7.1%
4,090,691
+0.3%
0.29%
-15.1%
Q4 2020$212,146,000
+185.7%
4,078,158
+47.0%
0.34%
+151.8%
Q3 2020$74,259,000
+68.3%
2,775,000
+22.5%
0.14%
+22.3%
Q2 2020$44,122,000
+186.5%
2,265,000
+44.7%
0.11%
+69.7%
Q1 2020$15,400,000
+38.7%
1,565,000
+56.5%
0.07%
+61.0%
Q4 2019$11,100,0001,000,0000.04%
Other shareholders
TG THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,890,000$15,800,4005.14%
Ghost Tree Capital, LLC 1,000,000$8,360,0002.75%
Soleus Capital Management, L.P. 2,884,382$24,113,4342.22%
M28 Capital Management LP 216,600$1,810,7762.08%
Paradigm Biocapital Advisors LP 3,619,015$30,254,9652.05%
683 Capital Management, LLC 1,350,000$11,286,0000.88%
Parkwood LLC 165,414$6,0810.66%
Spotlight Asset Group, Inc. 79,000$660,4400.60%
Pier Capital, LLC 392,709$3,283,0470.53%
Quantum Private Wealth, LLC 91,081$761,4380.36%
View complete list of TG THERAPEUTICS INC shareholders